类风湿关节炎患者的死亡原因:与一般人群的比较
研究比较了87,114例安大略省类风湿关节炎(RA)患者与348,456例年龄、性别、地区匹配的一般人群对照的死亡率和死因。RA患者全因死亡率为每10,000患者年232(95%CI 228-236),高于对照的184(95%CI 182-186)。RA患者潜在寿命损失约为对照的两倍,反映多数死因的死亡率比升高且死亡年龄更早。
要点
- RA患者全因死亡率为每10,000患者年232,高于一般人群的184。
- 两组主要死因均为循环系统疾病、癌症和呼吸系统疾病。
- RA患者<45岁时呼吸系统疾病和循环系统疾病的超额死亡率较高。
核心结论
- 在多数死因上,RA患者的死亡率高于一般人群。
- RA患者75岁前潜在寿命损失约为无RA者的两倍,反映多数死因的死亡率比更高且RA患者死亡年龄更早。
研究设计与样本
- 研究为基于安大略省2000至2013年的起始队列,纳入87,114例RA患者和348,456例年龄、性别、地区匹配的一般人群对照。
- 估计了全因、病因别和超额死亡率、死亡率比(MRR)以及潜在寿命损失(YPLL)。
主要发现
- 随访期间,RA患者死亡11,778例(14%),对照死亡32,472例(9%),随访人年分别为508,385和1,769,365。
- RA患者全因死亡率为每10,000患者年232(95%CI 228-236),对照为184(95%CI 182-186)。
- 两组主要死因均为循环系统疾病、癌症和呼吸系统疾病。
- RA患者相对于一般人群,全因和特定病因死亡率均升高,多数死因的MRR升高。
- 年龄别死亡率比显示,RA患者<45岁时呼吸系统疾病和循环系统疾病的超额死亡率较高。
关键数值与推荐
- RA患者全因死亡率为每10,000患者年232(95%CI 228-236),对照为184(95%CI 182-186)。
- RA患者YPLL为每10,000人7,436,无RA者为4,083。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare mortality rates, underlying causes of death, excess mortality, and years of potential life lost (YPLL) among patients with rheumatoid arthritis (RA) relative to the general population. METHODS: We studied an inception cohort of 87,114 Ontario-based RA patients and 348,456 age/sex/area-matched general population comparators from years 2000 to 2013. All-cause, cause-specific, and excess mortality rates, mortality rate ratios (MRRs), and the YPLL were estimated. RESULTS: A total of 11,778 RA patients (14%) and 32,472 comparators (9%) died during 508,385 and 1,769,365 patient-years of follow-up, respectively, for corresponding mortality rates of 232 (95% confidence interval [95% CI] 228-236) and 184 (95% CI 182-186) per 10,000 patient-years. The leading causes of death in both groups were diseases of the circulatory system, cancer, and respiratory conditions. Increased mortality for all-cause and specific causes was observed in RA patients relative to the general population. MRRs were elevated for most causes of death. Age-specific mortality ratios illustrated a high excess mortality among RA patients <45 years of age for respiratory disease and circulatory disease. The YPLL for RA patients was 7,436 per 10,000 persons, compared with 4,083 YPLL among those without RA. CONCLUSION: Among most causes of death, mortality rates were increased in RA patients relative to the general population. The potential life years lost (before the age of 75 years) among RA patients was roughly double that among those without RA, reflecting higher rate ratios for most causes of death and RA patients dying at earlier ages.
引用
- Widdifield J, Paterson JM, Huang A, et al. Causes of Death in Rheumatoid Arthritis: How Do They Compare to the General Population? Arthritis Care Res (Hoboken). 2018. PMID: 29512334. doi:10.1002/acr.23548
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。